Acknowledging the caveat that any observed differences could be due to a combination of true biological differences and batch effects across studies, we compared ASCL1-driven gene expression (defined by Borromeo et al.5) enrichment scores between the 80 treatment-naive and 18 relapsed SCLC samples. Here, ASCL1 is linked to small cell lung carcinoma.